Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Perhaps TPL can't make an announcement until

PTSC has been very predictable when it comes to providing PDS license receipts that occur shortly after a filing period. It's been reported regularly in the "Subsequent Events"section of the 10Q/K.

Even if a J2.5 settlement was to occur next week, IMO I would expect the numbers to still end up in the next filing. If my memory serves me correctly, past license receipts have shown up in the "Subsequent Events" section even when the licenses were issued two to three weeks after the end of a quarter.

Corrections welcome.

Share
New Message
Please login to post a reply